Jieli Hu

Key Laboratory Of Molecular Biology On Infectious Diseases Ministry Of Education
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A PEGylated nanobody against HBsAg exhibits pleiotropic antiviral efficacy in hepatitis B models.

A PEGylated nanobody against HBsAg exhibits pleiotropic antiviral efficacy in hepatitis B models.

Journal: Journal of nanobiotechnology

Published: September 22, 2025

Transcriptome-Wide Dynamics of m7G-Related LncRNAs during the Progression from HBV Infection to Hepatocellular Carcinoma.

Transcriptome-Wide Dynamics of m7G-Related LncRNAs during the Progression from HBV Infection to Hepatocellular Carcinoma.

Journal: Frontiers in bioscience (Landmark edition)

Published: July 21, 2023

Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice.

Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice.

Journal: European journal of medicinal chemistry

Published: December 01, 2022

Sphondin efficiently blocks HBsAg production and cccDNA transcription through promoting HBx degradation.

Sphondin efficiently blocks HBsAg production and cccDNA transcription through promoting HBx degradation.

Journal: Journal of medical virology

Published: September 04, 2022

Structure-Based Discovery of N-Sulfonylpiperidine-3-Carboxamides as Novel Capsid Assembly Modulators for Potent Inhibition of HBV Replication.

Structure-Based Discovery of N-Sulfonylpiperidine-3-Carboxamides as Novel Capsid Assembly Modulators for Potent Inhibition of HBV Replication.

Journal: Viruses

Published: December 22, 2021

Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record.

Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record.

Journal: Genes & diseases

Published: October 14, 2021

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.

Journal: Nature communications

Published: October 10, 2020

The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element.

The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element.

Journal: Medicine

Published: December 22, 2019

Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication.

Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication.

Journal: Biochemical and biophysical research communications

Published: December 02, 2019

Strategies to improve the fluorescent signal of the tripartite sfGFP system.

Strategies to improve the fluorescent signal of the tripartite sfGFP system.

Journal: Acta biochimica et biophysica Sinica

Published: October 17, 2019

ADAR1 promotes HBV replication through its deaminase domain.

ADAR1 promotes HBV replication through its deaminase domain.

Journal: Frontiers in bioscience (Landmark edition)

Published: October 06, 2019

Hepatitis B virus X protein modulates upregulation of DHX9 to promote viral DNA replication.

Hepatitis B virus X protein modulates upregulation of DHX9 to promote viral DNA replication.

Journal: Cellular microbiology

Published: September 06, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026